Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway

Beneficial Effect of Atorvastatin on Renal Function in Patients with Type 2 Diabetes

(2013) M Tanaka   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

TRENDS IN DOOR-TO-BALLOON TIME AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI

(2013) Angela L. Brennan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus

(2012) Peter P Toth et al.   Cardiovascular Diabetology

Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital

(2012) Shao-hua Wang et al.   Diabetes & Vascular Disease Research

High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation

(2011) Jun Hao et al.   BRITISH JOURNAL OF NUTRITION

Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats

(2011) Lin Lu et al.   Journal of Zhejiang University-SCIENCE B

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

(2010) SHARP Collaborative Group   AMERICAN HEART JOURNAL

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

(2010) S. E. Nielsen et al.   DIABETIC MEDICINE

Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men

(2010) André J. Tremblay et al.   JOURNAL OF LIPID RESEARCH

Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)

(2009) Helen M. Colhoun et al.   AMERICAN JOURNAL OF KIDNEY DISEASES